

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.08946722 |
| 2 | positive regulation of glycolytic process (GO:0045821) | 5.78395057 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 5.56573430 |
| 4 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.30499488 |
| 5 | regulation of sequestering of triglyceride (GO:0010889) | 5.15527849 |
| 6 | triglyceride catabolic process (GO:0019433) | 5.02172433 |
| 7 | glandular epithelial cell differentiation (GO:0002067) | 4.98107187 |
| 8 | detection of calcium ion (GO:0005513) | 4.97095546 |
| 9 | type B pancreatic cell development (GO:0003323) | 4.93728185 |
| 10 | endocrine pancreas development (GO:0031018) | 4.73219154 |
| 11 | neutral lipid catabolic process (GO:0046461) | 4.71988431 |
| 12 | acylglycerol catabolic process (GO:0046464) | 4.71988431 |
| 13 | negative regulation of gluconeogenesis (GO:0045721) | 4.66634137 |
| 14 | brown fat cell differentiation (GO:0050873) | 4.63534745 |
| 15 | white fat cell differentiation (GO:0050872) | 4.58221556 |
| 16 | biotin metabolic process (GO:0006768) | 4.42975326 |
| 17 | negative regulation of amino acid transport (GO:0051956) | 4.33446642 |
| 18 | insulin secretion (GO:0030073) | 4.32036080 |
| 19 | nitric oxide mediated signal transduction (GO:0007263) | 4.17429300 |
| 20 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.14658628 |
| 21 | positive regulation of insulin secretion (GO:0032024) | 3.99587755 |
| 22 | peptide hormone processing (GO:0016486) | 3.93277299 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.86840298 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 3.81593839 |
| 25 | cellular response to leptin stimulus (GO:0044320) | 3.79779128 |
| 26 | regulation of protein kinase A signaling (GO:0010738) | 3.78932692 |
| 27 | glycerolipid catabolic process (GO:0046503) | 3.78526515 |
| 28 | positive regulation of fatty acid oxidation (GO:0046321) | 3.75979567 |
| 29 | epithelial cell fate commitment (GO:0072148) | 3.73883028 |
| 30 | proline transport (GO:0015824) | 3.73438911 |
| 31 | triglyceride biosynthetic process (GO:0019432) | 3.71656152 |
| 32 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.65589551 |
| 33 | valine metabolic process (GO:0006573) | 3.64213328 |
| 34 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.64085843 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62753362 |
| 36 | carnitine shuttle (GO:0006853) | 3.58715604 |
| 37 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.56955161 |
| 38 | neutral lipid biosynthetic process (GO:0046460) | 3.56794711 |
| 39 | acylglycerol biosynthetic process (GO:0046463) | 3.56794711 |
| 40 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.52748824 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 3.51716201 |
| 42 | alanine transport (GO:0032328) | 3.50572509 |
| 43 | response to leptin (GO:0044321) | 3.44749486 |
| 44 | glandular epithelial cell development (GO:0002068) | 3.42707565 |
| 45 | glycine transport (GO:0015816) | 3.39918455 |
| 46 | lipid particle organization (GO:0034389) | 3.38969225 |
| 47 | positive regulation of peptide hormone secretion (GO:0090277) | 3.38826623 |
| 48 | vocalization behavior (GO:0071625) | 3.35787764 |
| 49 | transcytosis (GO:0045056) | 3.34494726 |
| 50 | positive regulation of peptide secretion (GO:0002793) | 3.31470961 |
| 51 | locomotory exploration behavior (GO:0035641) | 3.31394819 |
| 52 | striatum development (GO:0021756) | 3.31113677 |
| 53 | activation of protein kinase A activity (GO:0034199) | 3.30650508 |
| 54 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.25821954 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.24342289 |
| 56 | positive regulation of glucose import (GO:0046326) | 3.23421500 |
| 57 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.22448819 |
| 58 | cellular response to epinephrine stimulus (GO:0071872) | 3.21180071 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.21089667 |
| 60 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20470424 |
| 61 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.18938500 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.14577173 |
| 63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14432712 |
| 64 | * regulation of insulin secretion (GO:0050796) | 3.11595499 |
| 65 | long term synaptic depression (GO:0060292) | 3.11500299 |
| 66 | positive regulation of glycogen metabolic process (GO:0070875) | 3.09620938 |
| 67 | ketone body metabolic process (GO:1902224) | 3.05893999 |
| 68 | fatty acid homeostasis (GO:0055089) | 3.04238394 |
| 69 | norepinephrine metabolic process (GO:0042415) | 3.03301693 |
| 70 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.98337934 |
| 71 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.97620909 |
| 72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97133396 |
| 73 | regulation of energy homeostasis (GO:2000505) | 2.96698591 |
| 74 | * response to dietary excess (GO:0002021) | 2.96077765 |
| 75 | peptide hormone secretion (GO:0030072) | 2.95869504 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 2.95445654 |
| 77 | positive regulation of neurotransmitter transport (GO:0051590) | 2.95365411 |
| 78 | adult feeding behavior (GO:0008343) | 2.95137506 |
| 79 | regulation of cholesterol storage (GO:0010885) | 2.94787840 |
| 80 | regulation of gluconeogenesis (GO:0006111) | 2.94751728 |
| 81 | cAMP catabolic process (GO:0006198) | 2.94398498 |
| 82 | presynaptic membrane assembly (GO:0097105) | 2.92417468 |
| 83 | neuron-neuron synaptic transmission (GO:0007270) | 2.91813078 |
| 84 | succinate metabolic process (GO:0006105) | 2.90566803 |
| 85 | regulation of glucokinase activity (GO:0033131) | 2.90429569 |
| 86 | regulation of hexokinase activity (GO:1903299) | 2.90429569 |
| 87 | regulation of fatty acid oxidation (GO:0046320) | 2.89971105 |
| 88 | coenzyme A biosynthetic process (GO:0015937) | 2.89285454 |
| 89 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.89222832 |
| 90 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.87827891 |
| 91 | adrenergic receptor signaling pathway (GO:0071875) | 2.87757526 |
| 92 | peptide secretion (GO:0002790) | 2.87271274 |
| 93 | regulation of synapse structural plasticity (GO:0051823) | 2.87183387 |
| 94 | retinol metabolic process (GO:0042572) | 2.86385967 |
| 95 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.85487863 |
| 96 | neuronal action potential propagation (GO:0019227) | 2.83943889 |
| 97 | response to epinephrine (GO:0071871) | 2.83910517 |
| 98 | diacylglycerol metabolic process (GO:0046339) | 2.83332929 |
| 99 | negative regulation of amine transport (GO:0051953) | 2.81615881 |
| 100 | positive regulation of vesicle fusion (GO:0031340) | 2.80707696 |
| 101 | positive regulation of glucose transport (GO:0010828) | 2.80606596 |
| 102 | * regulation of peptide hormone secretion (GO:0090276) | 2.80560943 |
| 103 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.79819740 |
| 104 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.79489284 |
| 105 | prepulse inhibition (GO:0060134) | 2.79407459 |
| 106 | astrocyte differentiation (GO:0048708) | 2.79183062 |
| 107 | regulation of glycolytic process (GO:0006110) | 2.78959162 |
| 108 | chemosensory behavior (GO:0007635) | 2.78506199 |
| 109 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.77418547 |
| 110 | glycerol metabolic process (GO:0006071) | 2.76514515 |
| 111 | * regulation of peptide secretion (GO:0002791) | 2.75562966 |
| 112 | carnitine transmembrane transport (GO:1902603) | 2.74992535 |
| 113 | positive regulation of glomerulus development (GO:0090193) | 2.73858583 |
| 114 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.73594958 |
| 115 | synaptic vesicle exocytosis (GO:0016079) | 2.73448353 |
| 116 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.72767923 |
| 117 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72579237 |
| 118 | positive regulation of cellular carbohydrate metabolic process (GO:0010676) | 2.72400493 |
| 119 | glutamate receptor signaling pathway (GO:0007215) | 2.72293919 |
| 120 | inositol phosphate catabolic process (GO:0071545) | 2.72257348 |
| 121 | * response to glucose (GO:0009749) | 2.72251628 |
| 122 | ethanol oxidation (GO:0006069) | 2.71471536 |
| 123 | protein localization to synapse (GO:0035418) | 2.70440971 |
| 124 | long-term synaptic potentiation (GO:0060291) | 2.70298743 |
| 125 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.70231173 |
| 126 | glutamate secretion (GO:0014047) | 2.69951894 |
| 127 | adaptation of signaling pathway (GO:0023058) | 2.69888836 |
| 128 | membrane hyperpolarization (GO:0060081) | 2.69620937 |
| 129 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.69527819 |
| 130 | positive regulation of hormone secretion (GO:0046887) | 2.68987638 |
| 131 | L-serine transport (GO:0015825) | 2.68368914 |
| 132 | synaptic transmission, glutamatergic (GO:0035249) | 2.68216094 |
| 133 | exocrine pancreas development (GO:0031017) | 2.67160523 |
| 134 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.66521691 |
| 135 | negative regulation of organic acid transport (GO:0032891) | 2.66503377 |
| 136 | branched-chain amino acid metabolic process (GO:0009081) | 2.65985869 |
| 137 | triglyceride metabolic process (GO:0006641) | 2.65971656 |
| 138 | negative regulation of synaptic transmission (GO:0050805) | 2.65924438 |
| 139 | NADH metabolic process (GO:0006734) | 2.65863910 |
| 140 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.65026624 |
| 141 | negative regulation of lipid catabolic process (GO:0050995) | 2.64453412 |
| 142 | thioester biosynthetic process (GO:0035384) | 2.64313988 |
| 143 | acyl-CoA biosynthetic process (GO:0071616) | 2.64313988 |
| 144 | glycerophospholipid catabolic process (GO:0046475) | 2.64248219 |
| 145 | synaptic vesicle maturation (GO:0016188) | 2.63917731 |
| 146 | cellular response to catecholamine stimulus (GO:0071870) | 2.63471132 |
| 147 | cellular response to monoamine stimulus (GO:0071868) | 2.63471132 |
| 148 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.61422807 |
| 149 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61273175 |
| 150 | positive regulation of glucose metabolic process (GO:0010907) | 2.61243601 |
| 151 | cyclic nucleotide catabolic process (GO:0009214) | 2.59909778 |
| 152 | * lipid storage (GO:0019915) | 2.59265513 |
| 153 | synaptic transmission, dopaminergic (GO:0001963) | 2.58744462 |
| 154 | dendritic spine morphogenesis (GO:0060997) | 2.58475580 |
| 155 | inositol phosphate dephosphorylation (GO:0046855) | 2.58279318 |
| 156 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.58279318 |
| 157 | regulation of lipoprotein metabolic process (GO:0050746) | 2.56659304 |
| 158 | * response to monosaccharide (GO:0034284) | 2.54815710 |
| 159 | * response to hexose (GO:0009746) | 2.54286543 |
| 160 | calcium ion import (GO:0070509) | 2.53993128 |
| 161 | potassium ion export (GO:0071435) | 2.53840092 |
| 162 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.51482469 |
| 163 | * regulation of hormone secretion (GO:0046883) | 2.51356682 |
| 164 | positive regulation of gluconeogenesis (GO:0045722) | 2.50291608 |
| 165 | ovulation from ovarian follicle (GO:0001542) | 2.49796511 |
| 166 | response to catecholamine (GO:0071869) | 2.47904380 |
| 167 | response to monoamine (GO:0071867) | 2.47904380 |
| 168 | acylglycerol homeostasis (GO:0055090) | 2.46181862 |
| 169 | triglyceride homeostasis (GO:0070328) | 2.46181862 |
| 170 | positive regulation of carbohydrate metabolic process (GO:0045913) | 2.45776344 |
| 171 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45606257 |
| 172 | L-phenylalanine catabolic process (GO:0006559) | 2.45606257 |
| 173 | negative regulation of catecholamine secretion (GO:0033604) | 2.39212263 |
| 174 | auditory receptor cell differentiation (GO:0042491) | 2.38936403 |
| 175 | early endosome to late endosome transport (GO:0045022) | 2.36867067 |
| 176 | macroautophagy (GO:0016236) | 2.36774142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.41047773 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.64565716 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.33268015 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.07048691 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74364225 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65674619 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43720800 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43720800 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39581162 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33300601 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.29941053 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29193952 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13746945 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08924213 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06437337 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06284716 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02491912 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.93608756 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89079765 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.86338064 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85799132 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82892226 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.80438043 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75105596 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70595551 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64019416 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62832341 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61476914 |
| 29 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61044288 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60360725 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58344110 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57396666 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56140417 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56090619 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56006570 |
| 36 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54857498 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53499031 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52318077 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51020657 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50583993 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47169635 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45260376 |
| 43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43756657 |
| 44 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.43354197 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42169407 |
| 46 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41261308 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39684524 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39497145 |
| 49 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39008530 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38401233 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36430683 |
| 52 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.34288231 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32675587 |
| 54 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31783733 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31204981 |
| 56 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.30055207 |
| 57 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29590377 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28476328 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27060109 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26947192 |
| 61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.26582508 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26207951 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25845805 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25262116 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23814005 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20227292 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19700105 |
| 68 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19384416 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.19235880 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19146212 |
| 71 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.17967259 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17418713 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15615017 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15159657 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13693744 |
| 76 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13644150 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13474145 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13376773 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13187854 |
| 80 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.11337933 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11152240 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10364803 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09926646 |
| 84 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09900499 |
| 85 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07909826 |
| 86 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.07853765 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07288328 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.07098854 |
| 89 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06800042 |
| 90 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06790439 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06789220 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06731301 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06045767 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05732235 |
| 95 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04355452 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03954971 |
| 97 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03918461 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03779019 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03576826 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02299630 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02102830 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02102310 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01441749 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00582618 |
| 105 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00198596 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99991404 |
| 107 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99880988 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99819724 |
| 109 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.99350520 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99176922 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98669589 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97710321 |
| 113 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97137333 |
| 114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96746658 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96674804 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96194716 |
| 117 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95847132 |
| 118 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95837042 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94954118 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94954118 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94185489 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92758600 |
| 123 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92378039 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90866920 |
| 125 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90761923 |
| 126 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89854903 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89290071 |
| 128 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88568380 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88419289 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87367616 |
| 131 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87110610 |
| 132 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.87110610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.73527922 |
| 2 | MP0005666_abnormal_adipose_tissue | 3.98612642 |
| 3 | MP0000013_abnormal_adipose_tissue | 3.77072476 |
| 4 | MP0004130_abnormal_muscle_cell | 3.68559405 |
| 5 | MP0002876_abnormal_thyroid_physiology | 3.57077607 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.49323930 |
| 7 | MP0002822_catalepsy | 3.34444951 |
| 8 | MP0003122_maternal_imprinting | 3.24356298 |
| 9 | MP0005375_adipose_tissue_phenotype | 3.14936773 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.12753753 |
| 11 | MP0008004_abnormal_stomach_pH | 3.02485696 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.98643305 |
| 13 | MP0003880_abnormal_central_pattern | 2.89025989 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.50293333 |
| 15 | MP0000003_abnormal_adipose_tissue | 2.48587015 |
| 16 | MP0002971_abnormal_brown_adipose | 2.39702037 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.37594463 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.26528226 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.26071942 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.14698149 |
| 21 | MP0009745_abnormal_behavioral_response | 2.12294014 |
| 22 | MP0005535_abnormal_body_temperature | 2.11827741 |
| 23 | MP0004270_analgesia | 2.02958822 |
| 24 | MP0005334_abnormal_fat_pad | 2.01906088 |
| 25 | MP0003195_calcinosis | 1.96308615 |
| 26 | MP0009046_muscle_twitch | 1.93854662 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.92858392 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.88263464 |
| 29 | MP0003123_paternal_imprinting | 1.84834651 |
| 30 | MP0009115_abnormal_fat_cell | 1.84085411 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.77494435 |
| 32 | MP0001486_abnormal_startle_reflex | 1.74978809 |
| 33 | MP0003121_genomic_imprinting | 1.69972903 |
| 34 | MP0002064_seizures | 1.67357112 |
| 35 | MP0003690_abnormal_glial_cell | 1.67207068 |
| 36 | MP0002272_abnormal_nervous_system | 1.61484008 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.60251358 |
| 38 | MP0001661_extended_life_span | 1.57428603 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.56226626 |
| 40 | MP0003868_abnormal_feces_composition | 1.54446781 |
| 41 | MP0002163_abnormal_gland_morphology | 1.53122901 |
| 42 | MP0003959_abnormal_lean_body | 1.51510994 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.48411286 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 1.44753629 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.42291236 |
| 46 | MP0005448_abnormal_energy_balance | 1.41751833 |
| 47 | MP0002734_abnormal_mechanical_nocicepti | 1.41328731 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.40268513 |
| 49 | MP0004924_abnormal_behavior | 1.40268513 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.39875542 |
| 51 | MP0002970_abnormal_white_adipose | 1.37741793 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.33412582 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.30930948 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.28017597 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.24536685 |
| 56 | MP0005332_abnormal_amino_acid | 1.24507007 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.24428644 |
| 58 | MP0005452_abnormal_adipose_tissue | 1.24029885 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.22715576 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.22581206 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.21920028 |
| 62 | MP0008569_lethality_at_weaning | 1.21544797 |
| 63 | MP0003045_fibrosis | 1.20086095 |
| 64 | MP0002928_abnormal_bile_duct | 1.19640493 |
| 65 | MP0002733_abnormal_thermal_nociception | 1.19312291 |
| 66 | MP0003879_abnormal_hair_cell | 1.18378981 |
| 67 | MP0003633_abnormal_nervous_system | 1.16593634 |
| 68 | MP0005365_abnormal_bile_salt | 1.13723367 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.11937184 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.09851986 |
| 71 | MP0001756_abnormal_urination | 1.09842295 |
| 72 | MP0001177_atelectasis | 1.06955197 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.03753778 |
| 74 | MP0001970_abnormal_pain_threshold | 1.02924678 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.01968423 |
| 76 | MP0001440_abnormal_grooming_behavior | 1.00487189 |
| 77 | MP0004215_abnormal_myocardial_fiber | 0.99937001 |
| 78 | MP0004484_altered_response_of | 0.98347146 |
| 79 | MP0005409_darkened_coat_color | 0.97539562 |
| 80 | MP0003953_abnormal_hormone_level | 0.95112279 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.94435431 |
| 82 | MP0006276_abnormal_autonomic_nervous | 0.90873064 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.90424445 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.90262295 |
| 85 | MP0002736_abnormal_nociception_after | 0.90158219 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.88608054 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.87972549 |
| 88 | MP0005423_abnormal_somatic_nervous | 0.85979191 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.84675673 |
| 90 | MP0002557_abnormal_social/conspecific_i | 0.83847963 |
| 91 | MP0003646_muscle_fatigue | 0.83187043 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 0.81397842 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.81296889 |
| 94 | MP0008872_abnormal_physiological_respon | 0.81178286 |
| 95 | MP0004043_abnormal_pH_regulation | 0.80956748 |
| 96 | MP0008874_decreased_physiological_sensi | 0.80544469 |
| 97 | MP0001984_abnormal_olfaction | 0.79934558 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 0.78604501 |
| 99 | MP0001188_hyperpigmentation | 0.78319799 |
| 100 | MP0003787_abnormal_imprinting | 0.76902041 |
| 101 | MP0000751_myopathy | 0.76804804 |
| 102 | MP0003011_delayed_dark_adaptation | 0.76579362 |
| 103 | MP0005620_abnormal_muscle_contractility | 0.75381567 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.74183147 |
| 105 | MP0004085_abnormal_heartbeat | 0.72039682 |
| 106 | MP0003186_abnormal_redox_activity | 0.72030315 |
| 107 | MP0001529_abnormal_vocalization | 0.71464240 |
| 108 | MP0003075_altered_response_to | 0.70415198 |
| 109 | MP0003631_nervous_system_phenotype | 0.69504545 |
| 110 | MP0006138_congestive_heart_failure | 0.69251600 |
| 111 | MP0004272_abnormal_basement_membrane | 0.69209336 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.68600607 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.68094218 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.67435597 |
| 115 | MP0005275_abnormal_skin_tensile | 0.67402749 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.67212001 |
| 117 | MP0001764_abnormal_homeostasis | 0.66641258 |
| 118 | MP0002254_reproductive_system_inflammat | 0.66207528 |
| 119 | MP0005266_abnormal_metabolism | 0.66186046 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.65910197 |
| 121 | MP0000462_abnormal_digestive_system | 0.65543742 |
| 122 | MP0005253_abnormal_eye_physiology | 0.65091160 |
| 123 | MP0003948_abnormal_gas_homeostasis | 0.64982978 |
| 124 | MP0003283_abnormal_digestive_organ | 0.63668065 |
| 125 | MP0000470_abnormal_stomach_morphology | 0.63337922 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.63040401 |
| 127 | MP0004036_abnormal_muscle_relaxation | 0.62729992 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.62519539 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.61118970 |
| 130 | MP0001664_abnormal_digestion | 0.60973973 |
| 131 | MP0002090_abnormal_vision | 0.60431781 |
| 132 | MP0002693_abnormal_pancreas_physiology | 0.59777705 |
| 133 | MP0005595_abnormal_vascular_smooth | 0.59070233 |
| 134 | MP0002184_abnormal_innervation | 0.58506605 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.58049827 |
| 136 | MP0001502_abnormal_circadian_rhythm | 0.57864781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 6.89486834 |
| 2 | Focal motor seizures (HP:0011153) | 6.31238301 |
| 3 | Acanthosis nigricans (HP:0000956) | 4.84923497 |
| 4 | Hyperthyroidism (HP:0000836) | 4.38304463 |
| 5 | Symptomatic seizures (HP:0011145) | 4.35041989 |
| 6 | Myokymia (HP:0002411) | 4.12860511 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.98319588 |
| 8 | Focal seizures (HP:0007359) | 3.94618647 |
| 9 | Enlarged penis (HP:0000040) | 3.88756399 |
| 10 | Hypertriglyceridemia (HP:0002155) | 3.70514402 |
| 11 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.69397851 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.69397851 |
| 13 | Hyperglycinuria (HP:0003108) | 3.66689086 |
| 14 | Febrile seizures (HP:0002373) | 3.59250914 |
| 15 | Abnormal eating behavior (HP:0100738) | 3.52772336 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.51513748 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.41960651 |
| 18 | Resting tremor (HP:0002322) | 3.40644062 |
| 19 | Hyperventilation (HP:0002883) | 3.34770896 |
| 20 | Thyroid-stimulating hormone excess (HP:0002925) | 3.34447776 |
| 21 | Abnormal pancreas size (HP:0012094) | 3.29764482 |
| 22 | Late onset (HP:0003584) | 3.29364387 |
| 23 | Increased circulating renin level (HP:0000848) | 3.29339652 |
| 24 | Poor eye contact (HP:0000817) | 3.21481870 |
| 25 | Large for gestational age (HP:0001520) | 3.20778155 |
| 26 | Menstrual irregularities (HP:0000858) | 3.10116929 |
| 27 | Hyperphosphatemia (HP:0002905) | 3.07024027 |
| 28 | Testicular neoplasm (HP:0010788) | 3.00384489 |
| 29 | Action tremor (HP:0002345) | 2.99902993 |
| 30 | Atonic seizures (HP:0010819) | 2.99515968 |
| 31 | Hypsarrhythmia (HP:0002521) | 2.95565143 |
| 32 | Agitation (HP:0000713) | 2.93365329 |
| 33 | Impaired social interactions (HP:0000735) | 2.92853432 |
| 34 | Abnormal social behavior (HP:0012433) | 2.92853432 |
| 35 | Ketoacidosis (HP:0001993) | 2.92090062 |
| 36 | Visual hallucinations (HP:0002367) | 2.84611946 |
| 37 | Generalized tonic-clonic seizures (HP:0002069) | 2.83672000 |
| 38 | Growth hormone excess (HP:0000845) | 2.81393247 |
| 39 | Pheochromocytoma (HP:0002666) | 2.76410795 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 2.75731098 |
| 41 | Myoglobinuria (HP:0002913) | 2.75343550 |
| 42 | Broad-based gait (HP:0002136) | 2.74249876 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.72269230 |
| 44 | Amblyopia (HP:0000646) | 2.68174302 |
| 45 | Dysmetric saccades (HP:0000641) | 2.67839201 |
| 46 | Absence seizures (HP:0002121) | 2.67419098 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.65730696 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.65730696 |
| 49 | Dysdiadochokinesis (HP:0002075) | 2.64933911 |
| 50 | Neuroendocrine neoplasm (HP:0100634) | 2.63197185 |
| 51 | Long foot (HP:0001833) | 2.61200448 |
| 52 | Anxiety (HP:0000739) | 2.61184848 |
| 53 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.61154698 |
| 54 | Depression (HP:0000716) | 2.55158554 |
| 55 | Decreased circulating renin level (HP:0003351) | 2.53146751 |
| 56 | Dialeptic seizures (HP:0011146) | 2.52528786 |
| 57 | Ventricular fibrillation (HP:0001663) | 2.52392406 |
| 58 | Double outlet right ventricle (HP:0001719) | 2.50727020 |
| 59 | Congenital malformation of the right heart (HP:0011723) | 2.50727020 |
| 60 | Hemiparesis (HP:0001269) | 2.49155609 |
| 61 | Macroorchidism (HP:0000053) | 2.41325715 |
| 62 | Abnormality of vitamin B metabolism (HP:0004340) | 2.41046381 |
| 63 | Exocrine pancreatic insufficiency (HP:0001738) | 2.38989013 |
| 64 | Truncal ataxia (HP:0002078) | 2.38469492 |
| 65 | Hyperpituitarism (HP:0010514) | 2.33575266 |
| 66 | Hypothermia (HP:0002045) | 2.33225730 |
| 67 | Striae distensae (HP:0001065) | 2.28806416 |
| 68 | Type I diabetes mellitus (HP:0100651) | 2.28736933 |
| 69 | Abnormality of vitamin metabolism (HP:0100508) | 2.28455029 |
| 70 | Insulin resistance (HP:0000855) | 2.26605353 |
| 71 | Hematochezia (HP:0002573) | 2.26503960 |
| 72 | Intestinal atresia (HP:0011100) | 2.23954083 |
| 73 | Nuclear cataract (HP:0100018) | 2.23494302 |
| 74 | Limb hypertonia (HP:0002509) | 2.21426116 |
| 75 | Xanthomatosis (HP:0000991) | 2.20741924 |
| 76 | Pigmentary retinal degeneration (HP:0001146) | 2.20652124 |
| 77 | Postural tremor (HP:0002174) | 2.19960452 |
| 78 | Excessive salivation (HP:0003781) | 2.16270436 |
| 79 | Drooling (HP:0002307) | 2.16270436 |
| 80 | Hyperlipoproteinemia (HP:0010980) | 2.15425968 |
| 81 | Bone cyst (HP:0012062) | 2.14695893 |
| 82 | Testicular atrophy (HP:0000029) | 2.14627765 |
| 83 | Ketosis (HP:0001946) | 2.14545492 |
| 84 | Polyphagia (HP:0002591) | 2.14397652 |
| 85 | Hypercortisolism (HP:0001578) | 2.14121258 |
| 86 | Large hands (HP:0001176) | 2.14019227 |
| 87 | Abnormality of renin-angiotensin system (HP:0000847) | 2.13960122 |
| 88 | Dysmetria (HP:0001310) | 2.13712442 |
| 89 | Difficulty running (HP:0009046) | 2.10024637 |
| 90 | Accelerated skeletal maturation (HP:0005616) | 2.09824336 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 2.07381810 |
| 92 | Hyperalaninemia (HP:0003348) | 2.07381810 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07381810 |
| 94 | Bradycardia (HP:0001662) | 2.04780692 |
| 95 | Scanning speech (HP:0002168) | 2.04520590 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04515476 |
| 97 | Blue irides (HP:0000635) | 2.04319646 |
| 98 | Retinal atrophy (HP:0001105) | 2.04161288 |
| 99 | Increased CSF protein (HP:0002922) | 2.03558737 |
| 100 | Intention tremor (HP:0002080) | 2.01210805 |
| 101 | Hyperglycemia (HP:0003074) | 2.00014539 |
| 102 | Hypoglycemic seizures (HP:0002173) | 1.99574639 |
| 103 | Progressive cerebellar ataxia (HP:0002073) | 1.99444372 |
| 104 | Prominent metopic ridge (HP:0005487) | 1.97099398 |
| 105 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95985584 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95668708 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 1.95668708 |
| 108 | Epileptiform EEG discharges (HP:0011182) | 1.94311778 |
| 109 | Polygenic inheritance (HP:0010982) | 1.93663851 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93266575 |
| 111 | Hemiplegia (HP:0002301) | 1.93186734 |
| 112 | Conjunctival hamartoma (HP:0100780) | 1.92542379 |
| 113 | Hamartoma of the eye (HP:0010568) | 1.92181724 |
| 114 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91481600 |
| 115 | Exotropia (HP:0000577) | 1.91239826 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91039419 |
| 117 | Torticollis (HP:0000473) | 1.90367568 |
| 118 | Prolonged QT interval (HP:0001657) | 1.89768809 |
| 119 | Subcapsular cataract (HP:0000523) | 1.87822413 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87403509 |
| 121 | Increased muscle lipid content (HP:0009058) | 1.86317601 |
| 122 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.85459053 |
| 123 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.83594823 |
| 124 | Adrenal overactivity (HP:0002717) | 1.83504693 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.83038023 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.83038023 |
| 127 | Aplasia involving bones of the extremities (HP:0009825) | 1.83034245 |
| 128 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83034245 |
| 129 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83034245 |
| 130 | Hyperkalemia (HP:0002153) | 1.82488493 |
| 131 | Stereotypic behavior (HP:0000733) | 1.81142924 |
| 132 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80850791 |
| 133 | Tongue fasciculations (HP:0001308) | 1.80701261 |
| 134 | Bradykinesia (HP:0002067) | 1.80691003 |
| 135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80331330 |
| 136 | Focal dystonia (HP:0004373) | 1.79925808 |
| 137 | Gait ataxia (HP:0002066) | 1.79791504 |
| 138 | Hypomagnesemia (HP:0002917) | 1.79504101 |
| 139 | Muscular hypotonia of the trunk (HP:0008936) | 1.79479632 |
| 140 | Abnormality of the metopic suture (HP:0005556) | 1.79110848 |
| 141 | Abnormal EKG (HP:0003115) | 1.78882308 |
| 142 | Metaphyseal dysplasia (HP:0100255) | 1.78819948 |
| 143 | Prominent supraorbital ridges (HP:0000336) | 1.77822595 |
| 144 | Truncal obesity (HP:0001956) | 1.77576479 |
| 145 | Epidermoid cyst (HP:0200040) | 1.76918765 |
| 146 | Hyperparathyroidism (HP:0000843) | 1.76789872 |
| 147 | Renal cortical cysts (HP:0000803) | 1.76304894 |
| 148 | Impaired vibratory sensation (HP:0002495) | 1.76150936 |
| 149 | Abnormality of salivation (HP:0100755) | 1.75569591 |
| 150 | Congenital cataract (HP:0000519) | 1.74763378 |
| 151 | Downturned corners of mouth (HP:0002714) | 1.73577853 |
| 152 | Vascular calcification (HP:0004934) | 1.73245798 |
| 153 | Craniofacial dystonia (HP:0012179) | 1.71615542 |
| 154 | Syncope (HP:0001279) | 1.71483971 |
| 155 | Proximal tubulopathy (HP:0000114) | 1.67162544 |
| 156 | 3-Methylglutaconic aciduria (HP:0003535) | 1.65473082 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.58124900 |
| 158 | Glycosuria (HP:0003076) | 1.58124900 |
| 159 | Steatorrhea (HP:0002570) | 1.57065526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 4.96620902 |
| 2 | EPHA4 | 4.36927251 |
| 3 | CAMK1D | 4.08861168 |
| 4 | NTRK3 | 3.68845468 |
| 5 | CAMK1G | 3.27751855 |
| 6 | CASK | 2.43461461 |
| 7 | DAPK2 | 2.43391714 |
| 8 | TNIK | 2.42270305 |
| 9 | PRKD3 | 2.27807516 |
| 10 | INSRR | 2.24082370 |
| 11 | MAP2K6 | 2.07249792 |
| 12 | FRK | 1.98409946 |
| 13 | CAMKK2 | 1.95320768 |
| 14 | SIK1 | 1.88505397 |
| 15 | TRIB3 | 1.76237901 |
| 16 | NTRK1 | 1.76006077 |
| 17 | LMTK2 | 1.75949793 |
| 18 | ACVR1B | 1.73731917 |
| 19 | MAP3K4 | 1.73484138 |
| 20 | BCKDK | 1.72673158 |
| 21 | RIPK4 | 1.68997195 |
| 22 | PDK4 | 1.65971503 |
| 23 | PDK3 | 1.65971503 |
| 24 | PRPF4B | 1.62350273 |
| 25 | MAP2K7 | 1.59160329 |
| 26 | NTRK2 | 1.56781508 |
| 27 | NLK | 1.54320722 |
| 28 | MAP3K9 | 1.53977715 |
| 29 | HIPK2 | 1.53230667 |
| 30 | MINK1 | 1.52803110 |
| 31 | CAMKK1 | 1.51604540 |
| 32 | UHMK1 | 1.47018338 |
| 33 | TRPM7 | 1.45651335 |
| 34 | GRK1 | 1.39256320 |
| 35 | MAP4K2 | 1.33350338 |
| 36 | YES1 | 1.32839708 |
| 37 | KSR1 | 1.32686684 |
| 38 | TIE1 | 1.32316892 |
| 39 | FGFR2 | 1.28774465 |
| 40 | RIPK1 | 1.26134436 |
| 41 | MAP3K13 | 1.24118195 |
| 42 | KSR2 | 1.23672257 |
| 43 | MAP2K4 | 1.21744151 |
| 44 | DAPK1 | 1.20661067 |
| 45 | PAK6 | 1.19562911 |
| 46 | CDK5 | 1.17625922 |
| 47 | MAP3K2 | 1.17364746 |
| 48 | PRKAA2 | 1.16268870 |
| 49 | SIK3 | 1.11557638 |
| 50 | CAMK1 | 1.11548776 |
| 51 | CAMK2D | 1.09629364 |
| 52 | PDPK1 | 1.09056966 |
| 53 | BMPR2 | 1.08982016 |
| 54 | TESK1 | 1.03242459 |
| 55 | MAP3K12 | 1.02406342 |
| 56 | EPHA3 | 1.01908109 |
| 57 | MST1R | 1.00133427 |
| 58 | PRKCH | 0.98092340 |
| 59 | PDK1 | 0.96772315 |
| 60 | STK3 | 0.96394976 |
| 61 | PDK2 | 0.95899758 |
| 62 | TNK2 | 0.95616187 |
| 63 | PINK1 | 0.93789908 |
| 64 | STK38L | 0.91388773 |
| 65 | SGK1 | 0.90442601 |
| 66 | STK11 | 0.89749664 |
| 67 | IRAK3 | 0.89698132 |
| 68 | SGK2 | 0.89475459 |
| 69 | SGK494 | 0.86360226 |
| 70 | SGK223 | 0.86360226 |
| 71 | STK24 | 0.85818687 |
| 72 | MAP2K1 | 0.85062545 |
| 73 | PRKD2 | 0.84897129 |
| 74 | IRAK1 | 0.82758054 |
| 75 | PIK3CA | 0.82201182 |
| 76 | PLK2 | 0.81564062 |
| 77 | GRK5 | 0.81044266 |
| 78 | MAPK13 | 0.79739187 |
| 79 | AKT3 | 0.79215677 |
| 80 | MST4 | 0.77726711 |
| 81 | FGFR3 | 0.77667482 |
| 82 | SGK3 | 0.74647615 |
| 83 | SCYL2 | 0.74168386 |
| 84 | PHKG1 | 0.73250450 |
| 85 | PHKG2 | 0.73250450 |
| 86 | SIK2 | 0.73032916 |
| 87 | CDK9 | 0.71789659 |
| 88 | FES | 0.71119399 |
| 89 | ARAF | 0.67789718 |
| 90 | MARK2 | 0.67100202 |
| 91 | PTK2B | 0.67006525 |
| 92 | MAPK11 | 0.65489921 |
| 93 | MARK1 | 0.64016036 |
| 94 | PRKCG | 0.63482603 |
| 95 | ADRBK1 | 0.62884062 |
| 96 | PRKG1 | 0.62601006 |
| 97 | CAMK2A | 0.62487548 |
| 98 | FER | 0.61625008 |
| 99 | STK38 | 0.60427920 |
| 100 | PRKACG | 0.60069186 |
| 101 | RET | 0.58656618 |
| 102 | BCR | 0.58126546 |
| 103 | PRKCE | 0.57763313 |
| 104 | PRKAA1 | 0.57720504 |
| 105 | STK39 | 0.56359413 |
| 106 | MAP3K6 | 0.55228515 |
| 107 | RPS6KB1 | 0.52989515 |
| 108 | OXSR1 | 0.52962172 |
| 109 | CAMK2B | 0.52122022 |
| 110 | JAK1 | 0.50756164 |
| 111 | CDK3 | 0.49517464 |
| 112 | PRKACB | 0.49106518 |
| 113 | IRAK2 | 0.48734683 |
| 114 | CCNB1 | 0.47287184 |
| 115 | RPS6KA3 | 0.46696140 |
| 116 | PAK3 | 0.46353283 |
| 117 | PNCK | 0.46027301 |
| 118 | WNK4 | 0.44926921 |
| 119 | WNK3 | 0.43220617 |
| 120 | RAF1 | 0.42937361 |
| 121 | ABL2 | 0.42888172 |
| 122 | BMPR1B | 0.42349561 |
| 123 | PRKACA | 0.42210438 |
| 124 | PDGFRA | 0.41472617 |
| 125 | ADRBK2 | 0.39673699 |
| 126 | NEK6 | 0.38775197 |
| 127 | GSK3A | 0.37792837 |
| 128 | MAP3K1 | 0.37456492 |
| 129 | PRKCZ | 0.36994026 |
| 130 | MYLK | 0.36787274 |
| 131 | MKNK2 | 0.34755363 |
| 132 | JAK2 | 0.32903919 |
| 133 | PTK2 | 0.31778659 |
| 134 | LATS1 | 0.31561531 |
| 135 | OBSCN | 0.30396525 |
| 136 | IGF1R | 0.29540098 |
| 137 | EIF2AK2 | 0.28047637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.40674474 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.61164824 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.37276437 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.80996154 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.71871891 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.36154389 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30529486 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.17740463 |
| 9 | Renin secretion_Homo sapiens_hsa04924 | 2.12966537 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.08186780 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99224841 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.97190250 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93692065 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92779020 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.90708904 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90465271 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86803757 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.84307598 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79929579 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.76227704 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72821107 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.68178463 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60246509 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55213595 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.54207398 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.48985981 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.46117100 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.44168020 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41859066 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39345586 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39134479 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36994872 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34159539 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33903610 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.32879231 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31743556 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29129225 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28249803 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27496449 |
| 40 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27318531 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24130054 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21683166 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20042080 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.15364702 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.14934259 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.11111756 |
| 47 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.09126692 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08968221 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02741940 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01712044 |
| 51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.01158665 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00412595 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00223792 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98775657 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96904519 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92609671 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90646979 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89301625 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89047251 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88738516 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84495502 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84385854 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84332404 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82464861 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79532520 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79074959 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.78550576 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.78119173 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75534379 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74086610 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73877503 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.71989174 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.70667291 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68733456 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68469963 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.68397924 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.68280504 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67307463 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66251387 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.64686261 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64173516 |
| 82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60100600 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58366009 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58326368 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57364780 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56350826 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52699934 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51815197 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51786547 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51776624 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49681289 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49083703 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48619608 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.48445461 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47478165 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46874761 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46538558 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.46162036 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46145964 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45784283 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45360108 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44796677 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43073094 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42714694 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42688972 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42221704 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41856812 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41609476 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40959255 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39465164 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39336924 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38864094 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38768459 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38189388 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37858964 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35933719 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35875525 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35222128 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34508345 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32393696 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31413607 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29962219 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29779642 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28698652 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.28393843 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28169469 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.27819684 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27661136 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26922352 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25819571 |

